FDA Maintains Taylor Farms Link to Cyclospora Outbreak Despite False Positive Test

The FDA is facing renewed scrutiny after acknowledging that a lettuce sample initially linked to a multistate cyclosporiasis outbreak produced a false-positive test result.

The agency had previously identified shredded iceberg lettuce sourced from central Mexico and distributed by Taylor Farms as a possible source of contamination, prompting voluntary recalls and the removal of affected products from restaurant supply chains.

However, regulators now say that subsequent analysis found no confirmed positive samples for the Cyclospora parasite. The FDA later clarified that the lettuce sample initially believed to contain Cyclospora was a false positive. Nevertheless, the agency said its epidemiological and traceback data continue to support the investigation and the voluntary recall involving Taylor Farms products.

FDA Retracts False-Positive Test Result

Despite the testing error, the FDA maintains that epidemiological evidence still points to lettuce as the likely source of the outbreak, which has sickened thousands of people across dozens of states.

Taco Bell locations in five states were among the businesses connected to the illnesses, and the agency continues to investigate how the contamination may have entered the food supply.

More than 100 hospitalizations have been reported, though no deaths have been confirmed.

Food Safety Questions Remain

The incident highlights the difficult balance regulators must strike between acting quickly to protect public health and ensuring that the information released to consumers and businesses is accurate.

Detecting Cyclospora in fresh produce is notoriously complex, and food safety experts note that contaminated products are often consumed or discarded before laboratory confirmation can occur.

For retailers, grocers and restaurant operators, the controversy raises broader questions about supply-chain transparency, crisis communication and consumer trust.

Companies increasingly face pressure to respond rapidly to potential health threats, even when scientific evidence is still evolving. At the same time, false alarms can damage brand reputations, disrupt operations and create confusion among shoppers.